SOPALLA DUL: Open Payments
NPI 1205364817 · BURIEN, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,489 in 41 payments from 14 companies in 2025. Trend: 2023 $525 · 2024 $0 · 2025 $1,489
Food & beverage: $1,464Education: $24
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 6 | $369 |
| UCB, Inc. | 8 | $203 |
| PFIZER INC. | 2 | $190 |
| ABBVIE INC. | 2 | $139 |
| Janssen Biotech, Inc. | 7 | $139 |
| LEO Pharma Inc. | 1 | $105 |
| Amgen Inc. | 4 | $94 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $80 |
| Biofrontera Inc. | 2 | $46 |
| Galderma Laboratories, L.P. | 1 | $35 |
Products named: DUPIXENT, CIBINQO, Bimzelx, RINVOQ, TREMFYA, ADBRY, OTEZLA, ILUMYA.
Industry payments across WA — which companies pay providers there.
